The DOI matches its Crossref record; 315 of the 315 references it cites were found in a registry or an index.
Pharmacology and Therapeutics of Bronchodilators
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–315 of 315
Regular treatment with salmeterol for chronic asthma: serious adverse events
Cates, C. J., & Cates, M. J. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006363.pub2 · Cited by 83
Storms, W. W., Chervinsky, P., Ghannam, A. F., Bird, S. R., Hustad, C. M., & Edelman, J. M. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.05.008 · Cited by 82
Park, H., Yang, M., Park, C. ‐., Kim, T., Moon, H., Min, K. ‐., Kim, Y. Y., & Cho, S. ‐. (2009) · Allergy · doi:10.1111/j.1398-9995.2008.01876.x · Cited by 80
β2-Agonist and Anticholinergic Drugs in the Treatment of Lung Disease
Proskocil, B. J., & Fryer, A. D. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200504-038sr · Cited by 80
Tiotropium bromide is effective for severe asthma with noneosinophilic phenotype
Iwamoto, H., Yokoyama, A., Shiota, N., Shoda, H., Haruta, Y., Hattori, N., & Kohno, N. (2008) · European Respiratory Journal · doi:10.1183/09031936.00014108 · Cited by 80
Rapid onset of tolerance to beta-agonist bronchodilation
Haney, S. D., & Hancox, R. J. (2004) · Respiratory Medicine · doi:10.1016/j.rmed.2004.10.014 · Cited by 79
KCa3.1 Ca2+Activated K+ Channels Regulate Human Airway Smooth Muscle Proliferation
Shepherd, M. C., Duffy, S. M., Harris, T., Cruse, G., Schuliga, M. J., Brightling, C. E., Neylon, C. B., Bradding, P., & Stewart, A. G. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0358oc · Cited by 79
O'Reilly, J. F., Jones, M. M., Parnham, J., Lovibond, K., Rudolf, M., & on behalf of the Guideline Development Group (2010) · BMJ · doi:10.1136/bmj.c3134 · Cited by 79
In utero beta 2 adrenergic agonist exposure and adverse neurophysiologic and behavioral outcomes
Witter, F. R., Zimmerman, A. W., Reichmann, J. P., & Connors, S. L. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.07.010 · Cited by 77
The K+ channels KCa3.1 and Kv1.3 as novel targets for asthma therapy
Bradding, P. H., & Wulff, H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00362.x · Cited by 77
Redington, A. E. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.069 · Cited by 77
Glossop, P. A., Lane, C. A. L., Price, D. A., Bunnage, M. E., Lewthwaite, R. A., James, K., Brown, A. D., Yeadon, M., Huguet, C., Trevethick, M. A., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm1005989 · Cited by 77
Rodrigo, G. J., Plaza, V., García‐Marcos, L., & Castro-Rodríguez, J. A. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2008.10.008 · Cited by 76
Nials, A. T., Ball, D. I., Butchers, P. R., Coleman, R. A., Humbles, A. A., Johnson, M. W., & Vardey, C. J. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90392-1 · Cited by 75
Pro-inflammatory mechanisms of muscarinic receptor stimulation in airway smooth muscle
Oenema, T. A., Kolahian, S., Nanninga, J. E., Rieks, D., Hiemstra, P. S., Zuyderduyn, S., Halayko, A. J., Meurs, H., & Gosens, R. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-130 · Cited by 75
The design and bioactivation of presystemically stable prodrugs
Svensson, L.-Å., & Tunek, A. (1988) · Drug Metabolism Reviews · doi:10.3109/03602538809049622 · Cited by 73
Effects of Theophylline Withdrawal in Severe Chronic Obstructive Pulmonary Disease
Kirsten, D. K., Wegner, R., Jörres, R. A., & MAGNUSSEN, H. (1993) · CHEST Journal · doi:10.1378/chest.104.4.1101 · Cited by 70
Bronchodilator tolerance: the impact of increasing bronchoconstriction
Wraight, J., Hancox, R. J., Herbison, P., Cowan, J. O., Flannery, E. M., & Taylor, D. R. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00067503 · Cited by 70
Singer, A. J., Emerman, C. E., Char, D. M., Heywood, J. T., Kirk, J. D., Hollander, J. E., Summers, R. L., Lee, C. C., Wynne, J., Kellerman, L., et al. (2008) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2007.04.005 · Cited by 69
Hawkins, N. M., Wang, D., Petrie, M. C., Pfeffer, M. A., Swedberg, K. B., Granger, C. B., Yusuf, S., Solomon, S. D., Östergren, J., Michelson, E. L., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq040 · Cited by 67
Agonist efficacy and receptor desensitization: from partial truths to a fuller picture
Charlton, S. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00352.x · Cited by 67
Vestbo, J., Tan, L., Atkinson, G. F., & Ward, J. K. (2009) · European Respiratory Journal · doi:10.1183/09031936.00068908 · Cited by 67
Inhaled nitric oxide for respiratory failure in preterm infants
Barrington, K. J., & Finer, N. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000509.pub3 · Cited by 66
A Major Functional Role for Phosphodiesterase 4D5 in Human Airway Smooth Muscle Cells
Billington, C. K., Jeune, I. R. L., Young, K. W., et al. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0171oc · Cited by 65
Association between chronic heart failure and inhaled β-2-adrenoceptor agonists
Au, D. H., Udris, E. M., Curtis, J. R., McDonell, M. B., & Fihn, S. D. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.048 · Cited by 62
Tiotropium for Treatment of Stable COPD: A Meta-analysis of Clinically Relevant Outcomes
Yohannes, A. M., Willgoss, T. G., & Vestbo, J. (2011) · Respiratory Care · doi:10.4187/respcare.00852 · Cited by 62
Rho-Kinase as a Drug Target for the Treatment of Airway Hyperresponsiveness in Asthma
Gosens, R., Schaafsma, D., Nelemans, S. A., & Halayko, A. J. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706776073402 · Cited by 62
Page, C. P. (2010) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.04.002 · Cited by 61
Self-citation24-hour Bronchodilation following a single dose of the novel β2-agonist olodaterol in COPD
van Noord, J. A., Smeets, J. J., Drenth, B. M., Rascher, J., Pivovarova, A., Hamilton, A., & Cornelissen, P. J. G. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2011.07.006 · Cited by 60
Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.
Corris, P. A., Neville, E., Nariman, S., & Gibson, G. (1983) · Thorax · doi:10.1136/thx.38.4.292 · Cited by 59
Gongora, H. C., Wisniewski, A. F. Z., & Tattersfield, A. E. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.3_pt_1.626 · Cited by 59
Effects of short-term oral salbutamol administration on exercise endurance and metabolism
Collomp, K., Candau, R. B., Lasne, F., Labsy, Z., Prefaut, C., & de Ceaurriz, J. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.430 · Cited by 58
Agonist-Promoted Homologous Desensitization of Human Airway Smooth Muscle Bitter Taste Receptors
Robinett, K. S., Deshpande, D. A., Malone, M. M., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0061oc · Cited by 58
Theophylline pharmacokinetics in pregnancy
Frederiksen, M. C., Ruo, T. I., Chow, M. J., & Atkinson, A. J. (1986) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1986.183 · Cited by 57
Evidence for the involvement of cGMP in neural bronchodilator responses in humal trachea.
Ward, J. K., Barnes, P. J., Tadjkarimi, S., Yacoub, M. H., & Belvisi, M. G. (1995) · The Journal of Physiology · doi:10.1113/jphysiol.1995.sp020603 · Cited by 56
Regulatory Haplotypes in ARG1 Are Associated with Altered Bronchodilator Response
Duan, Q., Gaume, B. R., Hawkins, G. A., Himes, B. E., Bleecker, E. R., Klanderman, B. J., Irvin, C. G., Peters, S. P., Meyers, D. A., Hanrahan, J. P., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0758oc · Cited by 55
Novel bronchodilators in asthma
Cazzola, M., Segreti, A., & Matera, M. G. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32833303d2 · Cited by 55
Self-citationMetabolic Responses to Beta2 Stimulants
Smith, S. R., & Kendall, M. J. (1985) · Journal of the Royal College of Physicians of London · doi:10.1016/s0035-8819(25)02538-3 · Cited by 54
Matera, M. G., Calzetta, L., Passeri, D., Facciolo, F., Rendina, E. A., Page, C. P., Cazzola, M., & Orlandi, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01339.x · Cited by 53
Self-citationJansat, J. M., Lamarca, R., Gil, E. G., & Ferrer, P. (2009) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp47460 · Cited by 53
β2-Agonists at the Olympic Games
Fitch, K. D. (2006) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:31:2:259 · Cited by 53
PDE4-inhibitors: A novel, targeted therapy for obstructive airways disease
Diamant, Z., & Spina, D. (2011) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2010.12.011 · Cited by 53
El‐Tawil, S., Musa, T. A., Valli, H., Lunn, M. P., El-Tawil, T., & Weber, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005044.pub2 · Cited by 53
Glucocorticoid treatment decreases muscarinic receptor expression in canine airway smooth muscle
Emala, C. W., Clancy, J. P., & Hirshman, C. A. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.4.l745 · Cited by 52
LaForce, C., Alexander, M., Deckelmann, R., Fabbri, L. M., Айсанов, З. Р., Cameron, R., Owen, R. J., & Higgins, M. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01555.x · Cited by 52
Onoue, S., Yamada, S., & Yajima, T. (2007) · Peptides · doi:10.1016/j.peptides.2007.04.009 · Cited by 52
Carlsen, K. ‐., Hem, E., Stensrud, T., et al. (2001) · Respiratory Medicine · doi:10.1053/rmed.2001.1105 · Cited by 52
Krämer, B. (2010) · International Journal of COPD · doi:10.2147/copd.s12120 · Cited by 51
Adverse effects of salmeterol in asthma: a neuronal perspective
Lommatzsch, M., Lindner, Y., Edner, A., Bratke, K., Kuepper, M., & Virchow, J. C., Jr. (2009) · Thorax · doi:10.1136/thx.2008.110916 · Cited by 49
The β-Agonist Saga and Its Clinical Relevance: On and On It Goes
Taylor, D. R. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200901-0055cc · Cited by 48
Nannini, L. J., Cates, C. J., Lasserson, T. J., & Poole, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006826 · Cited by 48
Lipworth, B. J., McDevitt, D. G., & Struthers, A. D. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90438-5 · Cited by 47
Smet, P. A. G. M. D., Denneboom, W., Kramers, C., & Grol, R. P. T. M. (2007) · Drugs & Aging · doi:10.2165/00002512-200724090-00003 · Cited by 47
Gershon, A. S., Croxford, R., To, T. M., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-9-201105030-00003 · Cited by 46
The inactivation of noradrenaline and isoprenaline in dogs
Gryglewski, R. J., & Vane, J. R. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb10365.x · Cited by 45
Panebra, A., Wang, W. C., Malone, M. M., Pitter, D. R. G., Weiss, S. T., Hawkins, G. A., & Liggett, S. B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011819 · Cited by 45
Cazzola, M., Noschese, P., D’Amato, G., & Matera, M. G. (2002) · CHEST Journal · doi:10.1378/chest.121.1.230 · Cited by 44
Self-citationHanania, N. A. (2008) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2007.12.004 · Cited by 43
O’Byrne, P. M., van der Linde, J., Cockcroft, D. W., Gauvreau, G. M., Brannan, J. D., FitzGerald, M., Watson, R. M., Milot, J., Davis, B. E., O'Connor, M., et al. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.08.047 · Cited by 43
Hughes, A. D., & Jones, L. H. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.106 · Cited by 42
Matera, M. G., Martuscelli, E., & Cazzola, M. (2009) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2009.10.001 · Cited by 42
Self-citationGenetic association analysis of COPD candidate genes with bronchodilator responsiveness
Kim, W. J., Hersh, C. P., DeMeo, D. L., Reilly, J. J., & Silverman, E. K. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.10.025 · Cited by 42
Respiratory medicines for children: current evidence, unlicensed use and research priorities
Smyth, A. R., Barbato, A., Beydon, N., Bisgaard, H. F., Boeck, K. D., Brand, P. L. P., Bush, A., Fauroux, B., de Jongste, J. C., Korppi, M. O., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00139508 · Cited by 42
Effect of Age on Bronchodilator Response
Kradjan, W. A., Driesner, N. K., Abuan, T., Emmick, G., & Schoene, R. B. (1992) · CHEST Journal · doi:10.1378/chest.101.6.1545 · Cited by 41
Indacaterol: In Chronic Obstructive Pulmonary Disease
Moen, M. D. (2010) · Drugs · doi:10.2165/11203960-000000000-00000 · Cited by 38
Sichletidis, L., Kottakis, J., Marcou, S., Constantinidis, T., & Antoniades, A. (1999) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.1999.tb11699.x · Cited by 38
Call for withdrawal of LABA single-therapy inhaler in asthma
Beasley, R. W., Perrin, K., Weatherall, M., & Wijesinghe, M. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61158-0 · Cited by 36
Salmeterol and physical performance at ‐15°C in hghly trained nonasthmatic cross‐country skiers
Sue‐Chu, M., Sandsund, M., Helgerud, J., Reinertsen, R. E., & Bjermer, L. H. (1999) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.1999.tb00206.x · Cited by 35
Burniston, J. G., McLean, L., Beynon, R. J., & Goldspink, D. F. (2006) · Muscle & Nerve · doi:10.1002/mus.20684 · Cited by 35
Cazzola, M., Matera, M. G., Perna, F. D., Calderaro, F., Califano, C., & Vinciguerra, A. (1998) · Respiratory Medicine · doi:10.1016/s0954-6111(98)90121-4 · Cited by 35
Self-citationFernandes, L. B., Henry, P. J., & Goldie, R. G. (2007) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465807080740 · Cited by 35
Cazzola, M., D’Amato, M., Califano, C., Perna, F. D., F, C., Matera, M. G., & D’Amato, G. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)85135-9 · Cited by 34
Self-citationLocalisation and expression of β-adrenoceptor subtype mRNAs in human lung
Mak, J., Nishikawa, M., Haddad, E., Kwon, O. J., Hirst, S. J., Twort, C. H. C., & Barnes, P. J. (1996) · European Journal of Pharmacology · doi:10.1016/0014-2999(96)00104-5 · Cited by 34
Long acting beta 2 agonists and theophylline in stable chronic obstructive pulmonary disease
Cazzola, M., Donner, C. F., & Matera, M. G. (1999) · Thorax · doi:10.1136/thx.54.8.730 · Cited by 33
Self-citationEllis, J. L. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36540-1 · Cited by 33
Mechanism for the emetic side effect of xanthine bronchodilators
Howell, R. E., Muehsam, W. T., & Kinnier, W. J. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90123-9 · Cited by 32
Indacaterol for chronic obstructive pulmonary disease (COPD)
Cazzola, M., Proietto, A., & Matera, M. G. (2010) · Drugs of today · doi:10.1358/dot.2010.46.3.1450070 · Cited by 31
Self-citationSummerhill, S., Stroud, T., Nagendra, R., Huguet, C., & Trevethick, M. A. (2008) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2008.06.003 · Cited by 31
β-Agonist-associated Reduction in RGS5 Expression Promotes Airway Smooth Muscle Hyper-responsiveness
Yang, Z., Cooper, P. R., Damera, G., Mukhopadhyay, I., Cho, H., Kehrl, J. H., Panettieri, R. A., & Druey, K. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.212480 · Cited by 30
Hodder, R. V., Kesten, S., Menjoge, S., & Viel, K. (2007) · PubMed Central · Cited by 29
General strategy for the management of bronchial asthma in pregnancy
Liccardi, G., Cazzola, M., Canonica, G. W., D’Amato, M., D’Amato, M., & Passalacqua, G. (2003) · Respiratory Medicine · doi:10.1016/s0954-6111(03)00031-3 · Cited by 29
Self-citationCazzola, M., Noschese, P., Michele, F. D., D’Amato, M., & Matera, M. G. (2005) · Respiratory Medicine · doi:10.1016/j.rmed.2005.04.024 · Cited by 28
Self-citationSynergistic effects of the anti-cholinergic R,R-glycopyrrolate with anti-inflammatory drugs
Pahl, A. M., Bauhofer, A., Petzold, U., Cnota, P. J., Maus, J., Brune, K., & Szelenyi, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.025 · Cited by 28
Villetti, G., Pastore, F., Bergamaschi, M., Bassani, F., Bolzoni, P. T., Battipaglia, L., Amari, G., Rizzi, A., Delcanale, M., Volta, R., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170035 · Cited by 28
The Asthmatic Athlete, Inhaled Beta Agonists, and Performance
McKenzie, D. C., Stewart, I. B., & Fitch, K. D. (2002) · Clinical Journal of Sport Medicine · doi:10.1097/00042752-200207000-00004 · Cited by 27
A Nitric Oxide-Releasing Salbutamol Elicits Potent Relaxant and Anti-Inflammatory Activities
Lagente, V., Naline, E., Guénon, I., Corbel, M., Boichot, E., Burgaud, J., Soldato, P. D., & Advenier, C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061739 · Cited by 27
Pharmacology of Anti-Asthma Xanthines
Persson, C. G. A., & Pauwels, R. (1991) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-75855-3_7 · Cited by 27
Polverino, E., Gómez, F. P., Manrique, H. A., Soler, N., Roca, J., Barberà, J. A., & Rodriguez‐Roisin, R. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200612-1864oc · Cited by 26
Haney, S. D., & Hancox, R. J. (2007) · Respiratory Research · doi:10.1186/1465-9921-8-19 · Cited by 25
Pharmaceutical treatment of asthma symptoms in elite athletes – doping or therapy?
Backer, V., Lund, T. K., & Pedersen, L. (2007) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/j.1600-0838.2007.00711.x · Cited by 25
The effective treatment of COPD: Anticholinergics and what else?
Cazzola, M., & Matera, M. G. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.09.009 · Cited by 25
Self-citationCazzola, M., Centanni, S., & Donner, C. F. (1998) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.1999.0174 · Cited by 25
Self-citationReview: Safety of long-acting β2 -agonists in the treatment of asthma
Cazzola, M., & Matera, M. G. (2007) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465807081747 · Cited by 24
Self-citationBronchodilator Effect of Infused B-Type Natriuretic Peptide in Asthma
Akerman, M. J. H., Yaegashi, M., Khiangte, Z., Murugan, A. T., Abe, O., & Marmur, J. D. (2006) · CHEST Journal · doi:10.1378/chest.130.1.66 · Cited by 24
Um, S., Yoo, C., Kim, Y. W., Han, S., & Shim, Y.-S. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.5.839 · Cited by 24
An Explanation of the Asthma Paradox
Page, C. P. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.6_pt_2.s29 · Cited by 24
Self-citationThe dose‐related hyper‐and‐hypokalaemic effects of salbutamol and its arrhythmogenic potential
Plooy, W. J. D., Hay, L., Kahler, C. P., et al. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14025.x · Cited by 23
Should aminophylline be abandoned in the treatment of acute asthma in adults?
Hart, S. P. (2000) · QJM · doi:10.1093/qjmed/93.11.761 · Cited by 23
Cope, S. F., Capkun-Niggli, G., Gale, R., Jardim, J. R., & Jansen, J. P. (2011) · International Journal of COPD · doi:10.2147/copd.s18759 · Cited by 22
Nevin, B. J., & Broadley, K. J. (2004) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2004.04.002 · Cited by 20
Rational use of inotropic therapy in heart failure
Felker, G. M., & O’Connor, C. M. (2001) · Current Cardiology Reports · doi:10.1007/s11886-001-0035-8 · Cited by 20
Effects of Aerosol Ipratropium Bromide on Cardiac Vagal Tone
Lehrer, P. M., Hochron, S. M., Rausch, L., & Carr, R. E. (1994) · CHEST Journal · doi:10.1378/chest.105.6.1701 · Cited by 20
Salama, R., Young, P. M., Rogueda, P., Lallement, A., Iliev, I., & Traini, D. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.589837 · Cited by 20
Tesfamariam, B., Waldron, T. L., & Seymour, A. A. (1998) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(99)00006-4 · Cited by 19
Binding the receptor at both ends
Sprang, S. R. (2011) · Nature · doi:10.1038/469172a · Cited by 19
Inhalation by design: Dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD
Jones, L. H., Baldock, H., Bunnage, M. E., Burrows, J. L., Clarke, N., Coghlan, M., Entwistle, D. A., Fairman, D., Feeder, N., Fulton, C. K., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.10.132 · Cited by 18
Aging Does not Affect Beta‐Agonist Responsiveness after Methacholine‐Induced Bronchoconstriction
Parker, A. L. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52110.x · Cited by 17
Ohmori, Y., Maruyama, S., Kimura, R., Onoue, S., Matsumoto, A., Endo, K., Iwanaga, T., Kashimoto, K., & Yamada, S. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.04.029 · Cited by 16
Baldwin, D., Sivardeen, Z., Pavord, I. D., & Knox, A. J. (1994) · Thorax · doi:10.1136/thx.49.11.1103 · Cited by 14
Inoue, Y., Yoshizato, T., & Kawarabayashi, T. (2009) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2008.01001.x · Cited by 14
de Mey, C., Nassr, N., & Lahu, G. (2011) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-11-7 · Cited by 12
Canepa-Anson, R., Dawson, J. R., Kuan, P., Poole-Wilson, P. A., Sutton, G. C., Cockrill, B. L., & Reuben, S. R. (1987) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1987.tb03026.x · Cited by 10
Influence of Gene–gene Interactions on Response to Albuterol Therapy
Moore, P. E. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.192 · Cited by 6
Marshall, K. (2010) · PEARL (University of Plymouth) · doi:10.24382/93hq-tq60 · Cited by 4
Use and Safety of Long-Acting β 2 -agonists for Pediatric Asthma
Elkout, H., McLay, J. S., Simpson, C. R., & Helms, P. J. B. (2010) · Pediatric Health · doi:10.2217/phe.10.31 · Cited by 1
Cited by
β 2 -Agonist Therapy in Lung Disease
Cazzola, M., Page, C. P., Rogliani, P., & Matera, M. G. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201209-1739pp · Cited by 262
Self-citationSoukup, O., Winder, M., Killi, U. K., Wsol, V., Jun, D., Kuca, K., & Tobin, G. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666160607212615 · Cited by 34
Metadata
- Authors
- Cazzola, M., Page, C. P., Calzetta, L., & Matera, M. G.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 64
- Issue
- 3
- Pages
- 450-504
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2102590607
- Cited by
- 467
- References
- 315
- FWCI
- 28.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.